MAPT and Alzheimer disease: AD risk genes such as APOEε4 can induce the deposition of tau protein and Aβ in and out of cells of brain regions, lead to reduced neuronal activity and loss of synapses, and accelerate brain atrophy in related areas (Kim et al., 2014), further promote the conversion of aMCI to AD.